MEDICAL ELECTRODES MARKET ANALYSIS

Medical Electrodes Market, By Product Type (Surface Electrodes and Needle Electrodes), By Usability (Disposable Medical Electrodes and Reusable Medical Electrodes), By Modality (Electromyography, Electroencephalography, Electromyography, Brainstem Auditory Evoked Potentials, and Others), By Application (Cardiology, Neurophysiology, Electrosurgery, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In May 2023, NeuroOne Medical Technologies Corporation, a medtech company, announced that it had launched the Evo sEEG electrode. NeuroOne’s Evo sEEG electrode technology offers stereoelectroencephalography recording, brain stimulation, and future capabilities for spinal cord stimulation, and ablation solutions targeted for patients suffering from epilepsy, chronic back pain, and Parkinson’s disease.
In December 2023, Nahtlos AG, a medical technology company, announced the launch of a medically certified ECG Electrode patch for Movesense Sensors. Nahtlos Durastrip is the first Movesense compatible MDR certified ECG electrode which expands Nathlos Durastrip wearable platform.
In August 2022, NeuroPace, Inc., a commercial-stage medical device company, announced that it had entered into a distribution agreement with DIXI Medical USA, a provider of intracranial electrodes and instruments for neurosurgery. Under the terms of the agreement, NeuroPace, Inc. will have exclusive rights to promote and sell stereo electroencephalography (SEEG) electrodes in the U.S.
In January 2022, Koninklijke Philips NV, a medical technology company, announced the launch of the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company’s cardiac monitoring portfolio.